ADIPOQ and prostate carcinoma: A particularly relevant finding involves the association of combined low adiponectin (<6 μg/mL) and high leptin (>4 ng/mL) levels with a significantly increased risk of biochemical recurrence in prostate cancer patients treated with radical prostatectomy.